Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size, Status and Forecast 2025

January 2018 | 99 pages | ID: G58ED30C3CAEN
QYResearch

Abstracts

This report studies the global Pulmonary Arterial Hypertension (PAH) Medicine market, analyzes and researches the Pulmonary Arterial Hypertension (PAH) Medicine development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• Pfizer
• Gilead Sciences
• Eli Lilly
• Actelion Pharmaceuticals
• United Therapeutics Corporation

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Calcium Channel Blockers
• Novel Targeted Drugs
• Other

Market segment by Application, Pulmonary Arterial Hypertension (PAH) Medicine can be split into

• Secondary Pulmonary Hypertension (SPH)
• Primary Pulmonary Hypertension (PPH)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE

1.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Overview
  1.1.1 Pulmonary Arterial Hypertension (PAH) Medicine Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Pulmonary Arterial Hypertension (PAH) Medicine Market by Type
  1.3.1 Calcium Channel Blockers
  1.3.2 Novel Targeted Drugs
  1.3.3 Other
1.4 Pulmonary Arterial Hypertension (PAH) Medicine Market by End Users/Application
  1.4.1 Secondary Pulmonary Hypertension (SPH)
  1.4.2 Primary Pulmonary Hypertension (PPH)

2 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE COMPETITION ANALYSIS BY PLAYERS

2.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Pfizer
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Gilead Sciences
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Eli Lilly
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Actelion Pharmaceuticals
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 United Therapeutics Corporation
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments

4 GLOBAL PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018)
4.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
4.3 Potential Application of Pulmonary Arterial Hypertension (PAH) Medicine in Future
4.4 Top Consumer/End Users of Pulmonary Arterial Hypertension (PAH) Medicine

5 UNITED STATES PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
5.2 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
5.3 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

6 EU PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
6.2 EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
6.3 EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

7 JAPAN PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
7.2 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
7.3 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

8 CHINA PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE DEVELOPMENT STATUS AND OUTLOOK

8.1 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
8.2 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
8.3 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

9 INDIA PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE DEVELOPMENT STATUS AND OUTLOOK

9.1 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
9.2 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
9.3 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

10 SOUTHEAST ASIA PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
10.2 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
  11.1.2 EU Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
  11.1.4 China Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
  11.1.5 India Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
11.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Value) by Type (2018-2025)
11.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2018-2025)

12 PULMONARY ARTERIAL HYPERTENSION (PAH) MEDICINE MARKET DYNAMICS

12.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Opportunities
12.2 Pulmonary Arterial Hypertension (PAH) Medicine Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Pulmonary Arterial Hypertension (PAH) Medicine Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Pulmonary Arterial Hypertension (PAH) Medicine Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Regions (2013-2018)
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Type in 2017
Figure Calcium Channel Blockers Market Size (Million USD) and Growth Rate (2013-2018)
Figure Novel Targeted Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Other Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application in 2017
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate in Secondary Pulmonary Hypertension (SPH) (2013-2018)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate in Primary Pulmonary Hypertension (PPH) (2013-2018)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate in Applications 3 (2013-2018)
Table Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table Gilead Sciences Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of Gilead Sciences (2013-2018)
Figure Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of Eli Lilly (2013-2018)
Figure Eli Lilly Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table Actelion Pharmaceuticals Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of Actelion Pharmaceuticals (2013-2018)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table United Therapeutics Corporation Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of United Therapeutics Corporation (2013-2018)
Figure United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Product (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Product (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Product in 2017
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Pulmonary Arterial Hypertension (PAH) Medicine
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure EU Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure EU Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table India Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Growth Rate (2018-2025)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Regions (2018-2025)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share (2018-2025)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Regions in 2025
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Type (2018-2025)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Type in 2018
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Type in 2025
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Application (2018-2025)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Application in 2018
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Application in 2025